By comparing the enrichment of DEGs with SALL4 in GC, we demonstrated that high expression of SALL4 GC was more concentrated in several signaling pathways, such as Wnt/β-catenin, epithelial–mesenchymal transition, KRAS, and TGF-beta signaling pathways. The gene discussed is KRAS; the disease is gastric cancer.